These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28920528)

  • 41. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons.
    Bartos A; Fayette D
    Dement Geriatr Cogn Disord; 2018; 46(5-6):335-345. PubMed ID: 30513529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Montreal Cognitive Assessment: One Cutoff Never Fits All.
    Wong A; Law LS; Liu W; Wang Z; Lo ES; Lau A; Wong LK; Mok VC
    Stroke; 2015 Dec; 46(12):3547-50. PubMed ID: 26470772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Montreal cognitive assessment for evaluating cognitive impairment in multiple sclerosis: a systematic review.
    Rosca EC; Simu M
    Acta Neurol Belg; 2020 Dec; 120(6):1307-1321. PubMed ID: 32996098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decline in changing Montreal Cognitive Assessment (MoCA) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation.
    Tan HH; Xu J; Teoh HL; Chan BP; Seet RC; Venketasubramanian N; Sharma VK; Chen CL; Dong Y
    PLoS One; 2017; 12(3):e0173291. PubMed ID: 28346532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Underestimation of cognitive impairments by the Montreal Cognitive Assessment (MoCA) in an acute stroke unit population.
    Chan E; Khan S; Oliver R; Gill SK; Werring DJ; Cipolotti L
    J Neurol Sci; 2014 Aug; 343(1-2):176-9. PubMed ID: 24880539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Validity of the Montreal Cognitive Assessment for Moderate to Severe Traumatic Brain Injury Patients: A Pilot Study.
    Tay MRJ; Soh YM; Plunkett TK; Ong PL; Huang W; Kong KH
    Am J Phys Med Rehabil; 2019 Nov; 98(11):971-975. PubMed ID: 31136306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items.
    Lees RA; Hendry Ba K; Broomfield N; Stott D; Larner AJ; Quinn TJ
    Int J Geriatr Psychiatry; 2017 Oct; 32(10):1072-1078. PubMed ID: 27526678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment.
    Thomann AE; Berres M; Goettel N; Steiner LA; Monsch AU
    Alzheimers Res Ther; 2020 Apr; 12(1):39. PubMed ID: 32264975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores.
    Carson N; Leach L; Murphy KJ
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):379-388. PubMed ID: 28731508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of MMSE and MoCA in patients with acute ischemic stroke in clinical.
    Shen YJ; Wang WA; Huang FD; Chen J; Liu HY; Xia YL; Han M; Zhang L
    Int J Neurosci; 2016; 126(5):442-7. PubMed ID: 26000804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic accuracy of the Clock Drawing Test in screening for early post-stroke neurocognitive disorder: the Nor-COAST study.
    Navickaite E; Saltvedt I; Lydersen S; Munthe-Kaas R; Ihle-Hansen H; Grambaite R; Aam S
    BMC Neurol; 2024 Jan; 24(1):22. PubMed ID: 38195396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cog-4 has limited diagnostic test accuracy and validity for cognitive assessment in stroke survivors.
    Lees R; Lua J; Melling E; Miao Y; Tan J; Quinn TJ
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1604-10. PubMed ID: 24674952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery.
    Pendlebury ST; Welch SJ; Cuthbertson FC; Mariz J; Mehta Z; Rothwell PM
    Stroke; 2013 Jan; 44(1):227-9. PubMed ID: 23138443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.